The dipeptide carnosine is a physiologically important molecule in the human body, commonly found in skeletal muscle and brain tissue. Beta-alanine is a limiting precursor of carnosine and is among the most used sports supplements for improving athletic performance. However, carnosine, its metabolite N-acetylcarnosine, and the synthetic derivative zinc-L-carnosine have recently been gaining popularity as supplements in human medicine. These molecules have a wide range of effects-principally with anti-inflammatory, antioxidant, antiglycation, anticarbonylation, calcium-regulatory, immunomodulatory and chelating properties. This review discusses results from recent studies focusing on the impact of this supplementation in several areas of human medicine. We queried PubMed, Web of Science, the National Library of Medicine and the Cochrane Library, employing a search strategy using database-specific keywords. Evidence showed that the supplementation had a beneficial impact in the prevention of sarcopenia, the preservation of cognitive abilities and the improvement of neurodegenerative disorders. Furthermore, the improvement of diabetes mellitus parameters and symptoms of oral mucositis was seen, as well as the regression of esophagitis and taste disorders after chemotherapy, the protection of the gastrointestinal mucosa and the support of Helicobacter pylori eradication treatment. However, in the areas of senile cataracts, cardiovascular disease, schizophrenia and autistic disorders, the results are inconclusive.

Department of Medical Chemistry and Biochemistry Faculty of Medicine and Dentistry Palacky University 775 15 Olomouc Czech Republic

Department of Rehabilitaion University Hospital Olomouc 775 20 Olomouc Czech Republic

Department of Urology University Hospital Olomouc 775 20 Olomouc Czech Republic

Faculty of Medicine and Dentistry Palacky University 775 15 Olomouc Czech Republic

Zobrazit více v PubMed

Drozak J., Veiga-da-Cunha M., Vertommen D., Stroobant V., Van Schaftingen E. Molecular Identification of Carnosine Synthase as ATP-grasp Domain-containing Protein 1 (ATPGD1) J. Biol. Chem. 2010;285:9346–9356. doi: 10.1074/jbc.M109.095505. PubMed DOI PMC

Wu G. Important roles of dietary taurine, creatine, carnosine, anserine and 4-hydroxyproline in human nutrition and health. Amino Acids. 2020;52:329–360. doi: 10.1007/s00726-020-02823-6. PubMed DOI PMC

Xing L., Chee M.E., Zhang H., Zhang W., Mine Y. Carnosine—A natural bioactive dipeptide: Bioaccessibility, bioavailability and health benefits. J. Food. Bioact. 2019;5:8–17. doi: 10.31665/JFB.2019.5174. DOI

Haus J.M., Thyfault J.P. Therapeutic potential of carbonyl-scavenging carnosine derivative in metabolic disorders. J. Clin. Investig. 2018;128:5198–5200. doi: 10.1172/JCI124304. PubMed DOI PMC

Hipkiss A.R., Chana H. Carnosine Protects Proteins against Methylglyoxal-Mediated Modifications. Biochem. Biophys. Res. Commun. 1998;248:28–32. doi: 10.1006/bbrc.1998.8806. PubMed DOI

Dolan E., Saunders B., Dantas W.S., Murai I.H., Roschel H., Artioli G.G., Harris R., Bicudo J.E.P.W., Sale C., Gualano B. A Comparative Study of Hummingbirds and Chickens Provides Mechanistic Insight on the Histidine Containing Dipeptide Role in Skeletal Muscle Metabolism. Sci. Rep. 2018;8:14788. doi: 10.1038/s41598-018-32636-3. PubMed DOI PMC

Abdelkader H., Longman M., Alany R.G., Pierscionek B. On the Anticataractogenic Effects of L-Carnosine: Is It Best Described as an Antioxidant, Metal-Chelating Agent or Glycation Inhibitor? Oxid Med. Cell. Longev. 2016;2016:3240261. doi: 10.1155/2016/3240261. PubMed DOI PMC

Nicoletti V.G., Santoro A.M., Grasso G., Vagliasindi L.I., Giuffrida M.L., Cuppari C., Purrello V.S., Stella A.M.G., Rizzarelli E. Carnosine interaction with nitric oxide and astroglial cell protection. J. Neurosci. Res. 2007;85:2239–2245. doi: 10.1002/jnr.21365. PubMed DOI

Corona C., Frazzini V., Silvestri E., Lattanzio R., La Sorda R., Piantelli M., Canzoniero L.M.T., Ciavardelli D., Rizzarelli E., Sensi S.L. Effects of Dietary Supplementation of Carnosine on Mitochondrial Dysfunction, Amyloid Pathology, and Cognitive Deficits in 3xTg-AD Mice. PLoS ONE. 2011;6:e17971. doi: 10.1371/journal.pone.0017971. PubMed DOI PMC

Boldyrev A.A., Aldini G., Derave W. Physiology and Pathophysiology of Carnosine. Physiol. Rev. 2013;93:1803–1845. doi: 10.1152/physrev.00039.2012. PubMed DOI

Aldini G., de Courten B., Regazzoni L., Gilardoni E., Ferrario G., Baron G., Altomare A., D’Amato A., Vistoli G., Carini M. Understanding the antioxidant and carbonyl sequestering activity of carnosine: Direct and indirect mechanisms. Free Radic. Res. 2021;55:321–330. doi: 10.1080/10715762.2020.1856830. PubMed DOI

Holliday R., McFarland G.A. A role for carnosine in cellular maintenance. Biochemistry (Mosc.) 2000;65:843–848. PubMed

Villari V., Attanasio F., Micali N. Control of the Structural Stability of α-Crystallin under Thermal and Chemical Stress: The Role of Carnosine. J. Phys. Chem. B. 2014;118:13770–13776. doi: 10.1021/jp5092009. PubMed DOI

Nagai K., Suda T. Immunoregulative effects of carnosine and beta-alanine. Nihon Seirigaku Zasshi. 1986;48:564–571. PubMed

Hipkiss A.R., Baye E., de Courten B. Carnosine and the processes of ageing. Maturitas. 2016;93:28–33. doi: 10.1016/j.maturitas.2016.06.002. PubMed DOI

Turner M.D., Sale C., Garner A.C., Hipkiss A.R. Anti-cancer actions of carnosine and the restoration of normal cellular homeostasis. Biochim. Biophys. Acta—Mol. Cell Res. 2021;1868:119117. doi: 10.1016/j.bbamcr.2021.119117. PubMed DOI

Li X., Yang K., Gao S., Zhao J., Liu G., Chen Y., Lin H., Zhao W., Hu Z., Xu N. Carnosine Stimulates Macrophage-Mediated Clearance of Senescent Skin Cells Through Activation of the AKT2 Signaling Pathway by CD36 and RAGE. Front. Pharmacol. 2020;11:593832. doi: 10.3389/fphar.2020.593832. PubMed DOI PMC

Mikuła-Pietrasik J., Książek K. L-Carnosine Prevents the Pro-cancerogenic Activity of Senescent Peritoneal Mesothelium Towards Ovarian Cancer Cells. Anticancer Res. 2016;36:665–671. PubMed

Wu C.C., Lai P.Y., Hsieh S., Cheng C.C., Hsieh S.L. Suppression of Carnosine on Adhesion and Extravasation of Human Colorectal Cancer Cells. Anticancer Res. 2019;39:6135–6144. doi: 10.21873/anticanres.13821. PubMed DOI

Prakash M.D., Fraser S., Boer J.C., Plebanski M., de Courten B., Apostolopoulos V. Anti-Cancer Effects of Carnosine—A Dipeptide Molecule. Molecules. 2021;26:1644. doi: 10.3390/molecules26061644. PubMed DOI PMC

Hwang B., Shin S.S., Song J.H., Choi Y.H., Kim W.J., Moon S.K. Carnosine exerts antitumor activity against bladder cancers in vitro and in vivo via suppression of angiogenesis. J. Nutr. Biochem. 2019;74:108230. doi: 10.1016/j.jnutbio.2019.108230. PubMed DOI

Hipkiss A.R., Gaunitz F. Inhibition of tumour cell growth by carnosine: Some possible mechanisms. Amino Acids. 2014;46:327–337. doi: 10.1007/s00726-013-1627-5. PubMed DOI

Dolan E., Swinton P.A., de Salles Painelli V., Hemingway B.S., Mazzolani B., Smaira F.I., Saunders B., Artioli G.G., Gualano B. A Systematic Risk Assessment and Meta-Analysis on the Use of Oral β-Alanine Supplementation. Adv. Nutr. 2019;10:452–463. doi: 10.1093/advances/nmy115. PubMed DOI PMC

Saunders B., Elliott-Sale K., Artioli G.G., Swinton P.A., Dolan E., Roschel H., Sale C., Gualano B. β-alanine supplementation to improve exercise capacity and performance: A systematic review and meta-analysis. Br. J. Sports Med. 2017;51:658–669. doi: 10.1136/bjsports-2016-096396. PubMed DOI

Trexler E.T., Smith-Ryan A.E., Stout J.R., Hoffman J.R., Wilborn C.D., Sale C., Kreider R.B., Jäger R., Earnest C.P., Bannock L., et al. International society of sports nutrition position stand: Beta-Alanine. J. Int. Soc. Sports Nutr. 2015;12:30. doi: 10.1186/s12970-015-0090-y. PubMed DOI PMC

Turck D., Bohn T., Castenmiller J., De Henauw S., Hirsch-Ernst K.I., Maciuk A., Mangelsdorf I., McArdle H.J., Naska A., Pelaez C., et al. Safety of zinc l-carnosine as a Novel food pursuant to Regulation (EU) 2015/2283 and the bioavailability of zinc from this source in the context of Directive 2002/46/EC on food supplements. EFSA J. 2022;20:7332. doi: 10.2903/j.efsa.2022.7332. PubMed DOI PMC

Wu G. Amino Acids. CRC Press; Boca Raton, FL, USA: 2013. DOI

Artioli G.G., Sale C., Jones R.L. Carnosine in health and disease. Eur. J. Sport Sci. 2019;19:30–39. doi: 10.1080/17461391.2018.1444096. PubMed DOI

Spelnikov D., Harris R.C. A kinetic model of carnosine synthesis in human skeletal muscle. Amino Acids. 2019;51:115–121. doi: 10.1007/s00726-018-2646-z. PubMed DOI

Asatoor A.M., Bandoh J.K., Lant A.F., Milne M.D., Navab F. Intestinal absorption of carnosine and its constituent amino acids in man. Gut. 1970;11:250–254. doi: 10.1136/gut.11.3.250. PubMed DOI PMC

Chmielewska K., Dzierzbicka K., Inkielewicz-Stępniak I., Przybyłowska M. Therapeutic Potential of Carnosine and Its Derivatives in the Treatment of Human Diseases. Chem. Res. Toxicol. 2020;33:1561–1578. doi: 10.1021/acs.chemrestox.0c00010. PubMed DOI

Gaunitz F., Hipkiss A.R. Carnosine and cancer: A perspective. Amino Acids. 2012;43:135–142. doi: 10.1007/s00726-012-1271-5. PubMed DOI

Jin C.-L., Yang L.-X., Wu X.-H., Li Q., Ding M.-P., Fan Y.-Y., Zhang W.-P., Luo J.-H., Chen Z. Effects of carnosine on amygdaloid-kindled seizures in Sprague–Dawley rats. Neuroscience. 2005;135:939–947. doi: 10.1016/j.neuroscience.2005.06.066. PubMed DOI

Rocha S.M., Pires J., Esteves M., Graça B., Bernardino L. Histamine: A new immunomodulatory player in the neuron-glia crosstalk. Front. Cell. Neurosci. 2014;8:120. doi: 10.3389/fncel.2014.00120. PubMed DOI PMC

Charoensin S., Laopaiboon B., Boonkum W., Phetcharaburanin J., Villareal M.O., Isoda H., Duangjinda M. Thai Native Chicken as a Potential Functional Meat Source Rich in Anserine, Anserine/Carnosine, and Antioxidant Substances. Animals. 2021;11:902. doi: 10.3390/ani11030902. PubMed DOI PMC

Jones G., Smith M., Harris R. Imidazole dipeptide content of dietary sources commonly consumed within the British diet. Proc Nutr. Soc. 2011;70:E363. doi: 10.1017/S0029665111004484. DOI

Sarkar P., Kar K., Mondal M.C., Chakraborty I., Kar M. Elevated level of carbonyl compounds correlates with insulin resistance in type 2 diabetes. Ann. Acad. Med. Singapore. 2010;39:909–912. doi: 10.47102/annals-acadmedsg.V39N12p909. PubMed DOI

Freund M.A., Chen B., Decker E.A. The Inhibition of Advanced Glycation End Products by Carnosine and Other Natural Dipeptides to Reduce Diabetic and Age-Related Complications. Compr. Rev. Food Sci. Food Saf. 2018;17:1367–1378. doi: 10.1111/1541-4337.12376. PubMed DOI

de Courten B., Jakubova M., de Courten M.P., Kukurova I.J., Vallova S., Krumpolec P., Valkovic L., Kurdiova T., Garzon D., Barbaresi S., et al. Effects of carnosine supplementation on glucose metabolism: Pilot clinical trial. Obesity. 2016;24:1027–1034. doi: 10.1002/oby.21434. PubMed DOI

Siriwattanasit N., Satirapoj B., Supasyndh O. Effect of Oral carnosine supplementation on urinary TGF-β in diabetic nephropathy: A randomized controlled trial. BMC Nephrol. 2021;22:236. doi: 10.1186/s12882-021-02434-7. PubMed DOI PMC

Karkabounas S., Papadopoulos N., Anastasiadou C., Gubili C., Peschos D., Daskalou T., Fikioris N., Simos Y.V., Kontargiris E., Gianakopoulos X., et al. Effects of α -Lipoic Acid, Carnosine, and Thiamine Supplementation in Obese Patients with Type 2 Diabetes Mellitus: A Randomized, Double-Blind Study. J. Med. Food. 2018;21:1197–1203. doi: 10.1089/jmf.2018.0007. PubMed DOI

Nealon R.S., Sukala W.R. The Effect of 28 Days of Beta-alanine Supplementation on Exercise Capacity and Insulin Sensitivity in Individuals with Type 2 Diabetes Mellitus: A Randomised, Double-blind and Placebo-controlled Pilot Trial. Sport Nutr. Ther. 2016;1:1–7. doi: 10.4172/2473-6449.1000111. DOI

Elbarbary N.S., Ismail E.A.R., El-Naggar A.R., Hamouda M.H., El-Hamamsy M. The effect of 12 weeks carnosine supplementation on renal functional integrity and oxidative stress in pediatric patients with diabetic nephropathy: A randomized placebo-controlled trial. Pediatr. Diabetes. 2018;19:470–477. doi: 10.1111/pedi.12564. PubMed DOI

Houjeghani S., Kheirouri S., Faraji E., Jafarabadi M.A. l -Carnosine supplementation attenuated fasting glucose, triglycerides, advanced glycation end products, and tumor necrosis factor—α levels in patients with type 2 diabetes: A double-blind placebo-controlled randomized clinical trial. Nutr. Res. 2018;49:96–106. doi: 10.1016/j.nutres.2017.11.003. PubMed DOI

Matthews J.J., Dolan E., Swinton P.A., Santos L., Artioli G.G., Turner M.D., Elliott-Sale K.J., Sale C. Effect of Carnosine or β -Alanine Supplementation on Markers of Glycemic Control and Insulin Resistance in Humans and Animals: A Systematic Review and Meta-analysis. Adv. Nutr. 2021;12:2216–2231. doi: 10.1093/advances/nmab087. PubMed DOI PMC

Sureshkumar K., Durairaj M., Srinivasan K., Goh K.W., Undela K., Mahalingam V.T., Ardianto C., Ming L.C., Ganesan R.M. Effect of L-Carnosine in Patients with Age-Related Diseases: A Systematic Review and Meta-Analysis. Front. Biosci. 2023;28:18. doi: 10.31083/j.fbl2801018. PubMed DOI

Menon K., Marquina C., Liew D., Mousa A., Courten B. Histidine-containing dipeptides reduce central obesity and improve glycaemic outcomes: A systematic review and meta-analysis of randomized controlled trials. Obes. Rev. 2020;21:e12975. doi: 10.1111/obr.12975. PubMed DOI

Spaas J., Van Noten P., Keytsman C., Nieste I., Blancquaert L., Derave W., Eijnde B.O. Carnosine and skeletal muscle dysfunction in a rodent multiple sclerosis model. Amino Acids. 2021;53:1749–1761. doi: 10.1007/s00726-021-03086-5. PubMed DOI

Takeuchi K., Toyohara H., Sakaguchi M. A hyperosmotic stress-induced mRNA of carp cell encodes Na+- and Cl−-dependent high affinity taurine transporter1The sequence reported in this paper has been deposited in the DDBJ/EMBL/GenBank database with accession no. AB006986.1. Biochim. Biophys. Acta—Biomembr. 2000;1464:219–230. doi: 10.1016/S0005-2736(00)00158-9. PubMed DOI

Lenney J.F., George R.P., Weiss A.M., Kucera C.M., Chan P.W.H., Rinzler G.S. Human serum carnosinase: Characterization, distinction from cellular carnosinase, and activation by cadmium. Clin. Chim. Acta. 1982;123:221–231. doi: 10.1016/0009-8981(82)90166-8. PubMed DOI

Manoharan S., Guillemin G.J., Abiramasundari R.S., Essa M.M., Akbar M., Akbar M.D. The Role of Reactive Oxygen Species in the Pathogenesis of Alzheimer’s Disease, Parkinson’s Disease, and Huntington’s Disease: A Mini Review. Oxid. Med. Cell. Longev. 2016;2016:8590578. doi: 10.1155/2016/8590578. PubMed DOI PMC

Schön M., Mousa A., Berk M., Chia W.L., Ukropec J., Majid A., Ukropcová B., de Courten B. The Potential of Carnosine in Brain-Related Disorders: A Comprehensive Review of Current Evidence. Nutrients. 2019;11:1196. doi: 10.3390/nu11061196. PubMed DOI PMC

Rokicki J., Li L., Imabayashi E., Kaneko J., Hisatsune T., Matsuda H. Daily Carnosine and Anserine Supplementation Alters Verbal Episodic Memory and Resting State Network Connectivity in Healthy Elderly Adults. Front. Aging Neurosci. 2015;7:219. doi: 10.3389/fnagi.2015.00219. PubMed DOI PMC

Szcześniak D., Budzeń S., Kopeć W., Rymaszewska J. Anserine and carnosine supplementation in the elderly: Effects on cognitive functioning and physical capacity. Arch Gerontol. Geriatr. 2014;59:485–490. doi: 10.1016/j.archger.2014.04.008. PubMed DOI

Katakura Y., Totsuka M., Imabayashi E., Matsuda H., Hisatsune T. Anserine/Carnosine Supplementation Suppresses the Expression of the Inflammatory Chemokine CCL24 in Peripheral Blood Mononuclear Cells from Elderly People. Nutrients. 2017;9:1199. doi: 10.3390/nu9111199. PubMed DOI PMC

Hisatsune T., Kaneko J., Kurashige H., Cao Y., Satsu H., Totsuka M., Katakura Y., Imabayashi E., Matsuda H. Effect of Anserine/Carnosine Supplementation on Verbal Episodic Memory in Elderly People. J. Alzheimer’s Dis. 2015;50:149–159. doi: 10.3233/JAD-150767. PubMed DOI PMC

Baraniuk J.N., El-Amin S., Corey R., Rayhan R., Timbol C. Carnosine Treatment for Gulf War Illness: A Randomized Controlled Trial. Glob. J. Health Sci. 2013;5:69–81. doi: 10.5539/gjhs.v5n3p69. PubMed DOI PMC

Solis M.Y., Cooper S., Hobson R.M., Artioli G.G., Otaduy M.C., Roschel H., Robertson J., Martin D., Painelli V.S., Harris R.C., et al. Effects of Beta-Alanine Supplementation on Brain Homocarnosine/Carnosine Signal and Cognitive Function: An Exploratory Study. PLoS ONE. 2015;10:e0123857. doi: 10.1371/journal.pone.0123857. PubMed DOI PMC

Masuoka N., Yoshimine C., Hori M., Tanaka M., Asada T., Abe K., Hisatsune T. Effects of Anserine/Carnosine Supplementation on Mild Cognitive Impairment with APOE4. Nutrients. 2019;11:1626. doi: 10.3390/nu11071626. PubMed DOI PMC

Boldyrev A., Fedorova T., Stepanova M., Dobrotvorskaya I., Kozlova E., Boldanova N., Bagyeva G., Ivanova-Smolenskaya I., Illarioshkin S. Carnisone Increases Efficiency of DOPA Therapy of Parkinson’s Disease: A Pilot Study. Rejuvenation Res. 2008;11:821–827. doi: 10.1089/rej.2008.0716. PubMed DOI

Cornelli U. Treatment of Alzheimer’s Disease with a Cholinesterase Inhibitor Combined with Antioxidants. Neurodegener. Dis. 2010;7:193–202. doi: 10.1159/000295663. PubMed DOI

Checkoway H., Lundin J.I., Kelada S.N. Neurodegenerative diseases. IARC Sci. Publ. 2011;163:407–419. PubMed

Fonteh A.N., Harrington R.J., Tsai A., Liao P., Harrington M.G. Free amino acid and dipeptide changes in the body fluids from Alzheimer’s disease subjects. Amino Acids. 2007;32:213–224. doi: 10.1007/s00726-006-0409-8. PubMed DOI

Molina J.A., Jiménez-Jiménez F.J., Gomez P., Vargas C., Navarro J.A., Ortí-Pareja M., Gasalla T., Benito-León J., Bermejo F., Arenas J. Decreased cerebrospinal fluid levels of neutral and basic amino acids in patients with Parkinson’s disease. J. Neurol. Sci. 1997;150:123–127. doi: 10.1016/S0022-510X(97)00069-5. PubMed DOI

Millan M.J., Fone K., Steckler T., Horan W.P. Negative symptoms of schizophrenia: Clinical characteristics, pathophysiological substrates, experimental models and prospects for improved treatment. Eur. Neuropsychopharmacol. 2014;24:645–692. doi: 10.1016/j.euroneuro.2014.03.008. PubMed DOI

Beck K., Javitt D.C., Howes O.D. Targeting glutamate to treat schizophrenia: Lessons from recent clinical studies. Psychopharmacology (Berl.) 2016;233:2425–2428. doi: 10.1007/s00213-016-4318-6. PubMed DOI

Ghajar A., Khoaie-Ardakani M.-R., Shahmoradi Z., Alavi A.-R., Afarideh M., Shalbafan M.-R., Ghazizadeh-Hashemi M., Akhondzadeh S. L-carnosine as an add-on to risperidone for treatment of negative symptoms in patients with stable schizophrenia: A double-blind, randomized placebo-controlled trial. Psychiatry Res. 2018;262:94–101. doi: 10.1016/j.psychres.2018.02.012. PubMed DOI

Chengappa K.N.R., Turkin S.R., DeSanti S., Bowie C.R., Brar J.S., Schlicht P.J., Murphy S.L., Hetrick M.L., Bilder R., Fleet D. A preliminary, randomized, double-blind, placebo-controlled trial of l-carnosine to improve cognition in schizophrenia. Schizophr. Res. 2012;142:145–152. doi: 10.1016/j.schres.2012.10.001. PubMed DOI

Woo H.-I., Chun M.-R., Yang J.-S., Lim S.-W., Kim M.-J., Kim S.-W., Myung W.-J., Kim D.-K., Lee S.-Y. Plasma Amino Acid Profiling in Major Depressive Disorder Treated With Selective Serotonin Reuptake Inhibitors. CNS Neurosci. Ther. 2015;21:417–424. doi: 10.1111/cns.12372. PubMed DOI PMC

Ali-Sisto T., Tolmunen T., Kraav S.-L., Mäntyselkä P., Valkonen-Korhonen M., Honkalampi K., Ruusunen A., Velagapudi V., Lehto S.M. Serum levels of carnosine may be associated with the duration of MDD episodes. J. Affect Disord. 2023;320:647–655. doi: 10.1016/j.jad.2022.09.092. PubMed DOI

Sauer A.K., Stanton J.E., Hans S., Grabrucker A.M. Autism Spectrum Disorders. Exon Publications; Brisbane, Australia: 2021. Autism Spectrum Disorders: Etiology and Pathology. PubMed DOI

Anyachor C.P., Dooka D.B., Orish C.N., Amadi C.N., Bocca B., Ruggieri F., Senofonte M., Frazzoli C., Orisakwe O.E. Mechanistic considerations and biomarkers level in nickel-induced neurodegenerative diseases: An updated systematic review. IBRO Neurosci. Reports. 2022;13:136–146. doi: 10.1016/j.ibneur.2022.07.005. PubMed DOI PMC

Błażewicz A., Grabrucker A.M. Metal Profiles in Autism Spectrum Disorders: A Crosstalk between Toxic and Essential Metals. Int. J. Mol. Sci. 2022;24:308. doi: 10.3390/ijms24010308. PubMed DOI PMC

Abraham D.A., Undela K., Narasimhan U., Rajanandh M.G. Effect of L-Carnosine in children with autism spectrum disorders: A systematic review and meta-analysis of randomised controlled trials. Amino Acids. 2021;53:575–585. doi: 10.1007/s00726-021-02960-6. PubMed DOI

Bala K.A., Doğan M., Mutluer T., Kaba S., Aslan O., Balahoroğlu R., Çokluk E., Üstyol L., Kocaman S. Plasma amino acid profile in autism spectrum disorder (ASD) Eur. Rev. Med. Pharmacol. Sci. 2016;20:923–929. PubMed

Ming X., Stein T.P., Barnes V., Rhodes N., Guo L. Metabolic Perturbance in Autism Spectrum Disorders: A Metabolomics Study. J. Proteome Res. 2012;11:5856–5862. doi: 10.1021/pr300910n. PubMed DOI

Chez M.G., Buchanan C.P., Aimonovitch M.C., Becker M., Schaefer K., Black C., Komen J. Double-Blind, Placebo-Controlled Study of L-Carnosine Supplementation in Children with Autistic Spectrum Disorders. J. Child Neurol. 2002;17:833–837. doi: 10.1177/08830738020170111501. PubMed DOI

Mehrazad-Saber Z., Kheirouri S., Noorazar S.G. Effects of l-Carnosine Supplementation on Sleep Disorders and Disease Severity in Autistic Children: A Randomized, Controlled Clinical Trial. Basic Clin. Pharmacol. Toxicol. 2018;123:72–77. doi: 10.1111/bcpt.12979. PubMed DOI

Hajizadeh-Zaker R., Ghajar A., Mesgarpour B., Afarideh M., Mohammadi M.R., Akhondzadeh S. l-Carnosine As an Adjunctive Therapy to Risperidone in Children with Autistic Disorder: A Randomized, Double-Blind, Placebo-Controlled Trial. J. Child Adolesc. Psychopharmacol. 2018;28:74–81. doi: 10.1089/cap.2017.0026. PubMed DOI

Ghajar A., Aghajan-Nashtaei F., Afarideh M., Mohammadi M.R., Akhondzadeh S. l-Carnosine as Adjunctive Therapy in Children and Adolescents with Attention-Deficit/Hyperactivity Disorder: A Randomized, Double-Blind, Placebo-Controlled Clinical Trial. J. Child Adolesc. Psychopharmacol. 2018;28:331–338. doi: 10.1089/cap.2017.0157. PubMed DOI

Esposito D., Belli A., Ferri R., Bruni O. Sleeping without Prescription: Management of Sleep Disorders in Children with Autism with Non-Pharmacological Interventions and over-the-Counter Treatments. Brain Sci. 2020;10:441. doi: 10.3390/brainsci10070441. PubMed DOI PMC

Siafis S., Çıray O., Wu H., Schneider-Thoma J., Bighelli I., Krause M., Rodolico A., Ceraso A., Deste G., Huhn M., et al. Pharmacological and dietary-supplement treatments for autism spectrum disorder: A systematic review and network meta-analysis. Mol. Autism. 2022;13:10. doi: 10.1186/s13229-022-00488-4. PubMed DOI PMC

Ann Abraham D., Narasimhan U., Christy S., Muhasaparur Ganesan R. Effect of l-Carnosine as adjunctive therapy in the management of children with autism spectrum disorder: A randomized controlled study. Amino Acids. 2020;52:1521–1528. doi: 10.1007/s00726-020-02909-1. PubMed DOI

Lindfield R., Vishwanath K., Ngounou F., Khanna R. The challenges in improving outcome of cataract surgery in low and middle income countries. Indian J. Ophthalmol. 2012;60:464. doi: 10.4103/0301-4738.100552. PubMed DOI PMC

Wang A.M., Ma C., Xie Z.H., Shen F. Use of carnosine as a natural anti-senescence drug for human beings. Biochemistry (Mosc). 2000;65:869–871. PubMed

Babizhayev M.A., Deyev A.I., Yermakova V.N., Semiletov Y.A., Davydova N.G., Kurysheva N.I., Zhukotskii A.V., Goldman I.M. N-Acetylcarnosine, a natural histidine-containing dipeptide, as a potent ophthalmic drug in treatment of human cataracts. Peptides. 2001;22:979–994. doi: 10.1016/S0196-9781(01)00407-7. PubMed DOI

Babizhayev M., Kasus-Jacobi A. State of the Art Clinical Efficacy and Safety Evaluation of N-acetylcarnosine Dipeptide Ophthalmic Prodrug. Principles for the Delivery, Self-Bioactivation, Molecular Targets and Interaction with a Highly Evolved Histidyl-Hydrazide Structure in the Treatm. Curr. Clin. Pharmacol. 2009;4:4–37. doi: 10.2174/157488409787236074. PubMed DOI

Babizhayev M.A., Burke L., Micans P., Richer S.P. N-acetylcarnosine sustained drug delivery eye drops to control the signs of ageless vision: Glare sensitivity, cataract amelioration and quality of vision currently available treatment for the challenging 50,000-patient population. Clin. Interv. Aging. 2009;4:31–50. doi: 10.2147/CIA.S4090. PubMed DOI PMC

Dubois V.D.P., Bastawrous A. N-acetylcarnosine (NAC) drops for age-related cataract. Cochrane Database Syst. Rev. 2017;2:CD009493. doi: 10.1002/14651858.CD009493.pub2. PubMed DOI PMC

Yang Q.-J., Zhao J.-R., Hao J., Li B., Huo Y., Han Y.-L., Wan L.-L., Li J., Huang J., Lu J., et al. Serum and urine metabolomics study reveals a distinct diagnostic model for cancer cachexia. J. Cachexia Sarcopenia Muscle. 2018;9:71–85. doi: 10.1002/jcsm.12246. PubMed DOI PMC

Stuerenburg H.J. The roles of carnosine in aging of skeletal muscle and in neuromuscular diseases. Biochemistry (Mosc.) 2000;65:862–865. PubMed

Hipkiss A.R. Would Carnosine or a Carnivorous Diet Help Suppress Aging and Associated Pathologies? Ann. N. Y. Acad. Sci. 2006;1067:369–374. doi: 10.1196/annals.1354.052. PubMed DOI

Hipkiss A.R. Glycation, ageing and carnosine: Are carnivorous diets beneficial? Mech. Ageing Dev. 2005;126:1034–1039. doi: 10.1016/j.mad.2005.05.002. PubMed DOI

del Favero S., Roschel H., Solis M.Y., Hayashi A.P., Artioli G.G., Otaduy M.C., Benatti F.B., Harris R.C., Wise J.A., Leite C.C., et al. Beta-alanine (CarnosynTM) supplementation in elderly subjects (60–80 years): Effects on muscle carnosine content and physical capacity. Amino Acids. 2012;43:49–56. doi: 10.1007/s00726-011-1190-x. PubMed DOI PMC

McCormack W.P., Stout J.R., Emerson N.S., Scanlon T.C., Warren A.M., Wells A.J., Gonzalez A.M., Mangine G.T., Robinson E.H., 4th, Fragala M.S., et al. Oral nutritional supplement fortified with beta-alanine improves physical working capacity in older adults: A randomized, placebo-controlled study. Exp. Gerontol. 2013;48:933–939. doi: 10.1016/j.exger.2013.06.003. PubMed DOI

Furst T., Massaro A., Miller C., Williams B.T., LaMacchia Z.M., Horvath P.J. β-Alanine supplementation increased physical performance and improved executive function following endurance exercise in middle aged individuals. J. Int. Soc. Sports Nutr. 2018;15:32. doi: 10.1186/s12970-018-0238-7. PubMed DOI PMC

Dubois-Deruy E., Peugnet V., Turkieh A., Pinet F. Oxidative Stress in Cardiovascular Diseases. Antioxidants. 2020;9:864. doi: 10.3390/antiox9090864. PubMed DOI PMC

Roberts P.R., Zaloga G.P. Cardiovascular effects of carnosine. Biochemistry (Mosc.) 2000;65:856–861. PubMed

Stvolinsky S.L., Dobrota D. Anti-ischemic activity of carnosine. Biochemistry (Mosc.) 2000;65:849–855. PubMed

Lombardi C., Carubelli V., Lazzarini V., Vizzardi E., Bordonali T., Ciccarese C., Castrini A.I., Cas A.D., Nodari S., Metra M. Effects of oral administration of orodispersible levo-carnosine on quality of life and exercise performance in patients with chronic heart failure. Nutrition. 2015;31:72–78. doi: 10.1016/j.nut.2014.04.021. PubMed DOI

Yoshikawa F., Nakajima T., Hanada M., Hirata K., Masuyama T., Aikawa R. Beneficial effect of polaprezinc on cardiac function post-myocardial infarction: A prospective and randomized clinical trial. Medicine. 2019;98:e14637. doi: 10.1097/MD.0000000000014637. PubMed DOI PMC

Hall A.G., King J.C. Zinc Fortification: Current Trends and Strategies. Nutrients. 2022;14:3895. doi: 10.3390/nu14193895. PubMed DOI PMC

Li M., Sun Z., Zhang H., Liu Z. Recent advances on polaprezinc for medical use (Review) Exp. Ther. Med. 2021;22:1445. doi: 10.3892/etm.2021.10880. PubMed DOI PMC

Tang W., Liu H., Ooi T.C., Rajab N.F., Cao H., Sharif R. Zinc carnosine: Frontiers advances of supplement for cancer therapy. Biomed Pharmacother. 2022;151:113157. doi: 10.1016/j.biopha.2022.113157. PubMed DOI

Hewlings S.J., Medeiros D.M. Nutrition: Real People, Real Choices. Pearson Prentice Hall; Upper Saddle River, NJ, USA: 2008.

Sakagami M., Ikeda M., Tomita H., Ikui A., Aiba T., Takeda N., Inokuchi A., Kurono Y., Nakashima M., Shibasaki Y., et al. A zinc-containing compound, Polaprezinc, is effective for patients with taste disorders: Randomized, double-blind, placebo-controlled, multi-center study. Acta Otolaryngol. 2009;129:1115–1120. doi: 10.1080/00016480802552550. PubMed DOI

Fujii H., Hirose C., Ishihara M., Iihara H., Imai H., Tanaka Y., Matsuhashi N., Takahashi T., Yamaguchi K., Yoshida K., et al. Improvement of Dysgeusia by Polaprezinc, a Zinc-L-carnosine, in Outpatients Receiving Cancer Chemotherapy. Anticancer. Res. 2018;38:6367–6373. doi: 10.21873/anticanres.12995. PubMed DOI

Doi H., Fujiwara M., Suzuki H., Niwa Y., Nakayama M., Shikata T., Odawara S., Takada Y., Kimura T., Kamikonya N., et al. Polaprezinc reduces the severity of radiation-induced mucositis in head and neck cancer patients. Mol. Clin. Oncol. 2015;3:381–386. doi: 10.3892/mco.2014.479. PubMed DOI PMC

Hayashi H., Kobayashi R., Suzuki A., Ishihara M., Nakamura N., Kitagawa J., Kanemura N., Kasahara S., Kitaichi K., Hara T., et al. Polaprezinc prevents oral mucositis in patients treated with high-dose chemotherapy followed by hematopoietic stem cell transplantation. Anticancer Res. 2014;34:7271–7277. PubMed

Hayashi H., Kobayashi R., Suzuki A., Yamada Y., Ishida M., Shakui T., Kitagawa J., Hayashi H., Sugiyama T., Takeuchi H., et al. Preparation and clinical evaluation of a novel lozenge containing polaprezinc, a zinc-L-carnosine, for prevention of oral mucositis in patients with hematological cancer who received high-dose chemotherapy. Med. Oncol. 2016;33:91. doi: 10.1007/s12032-016-0795-z. PubMed DOI PMC

Suzuki A., Kobayashi R., Shakui T., Kubota Y., Fukita M., Kuze B., Aoki M., Sugiyama T., Mizuta K., Itoh Y. Effect of polaprezinc on oral mucositis, irradiation period, and time to discharge in patients with head and neck cancer. Head Neck. 2016;38:1387–1392. doi: 10.1002/hed.24446. PubMed DOI

Mahmood A., FitzGerald A.J., Marchbank T., Ntatsaki E., Murray D., Ghosh S., Playford R.J. Zinc carnosine, a health food supplement that stabilises small bowel integrity and stimulates gut repair processes. Gut. 2007;56:168–175. doi: 10.1136/gut.2006.099929. PubMed DOI PMC

Watanabe T., Ishihara M., Matsuura K., Mizuta K., Itoh Y. Polaprezinc prevents oral mucositis associated with radiochemotherapy in patients with head and neck cancer. Int. J. Cancer. 2010;127:1984–1990. doi: 10.1002/ijc.25200. PubMed DOI

Yanase K., Funaguchi N., Iihara H., Yamada M., Kaito D., Endo J., Ito F., Ohno Y., Tanaka H., Itoh Y., et al. Prevention of radiation esophagitis by polaprezinc (zinc L-carnosine) in patients with non-small cell lung cancer who received chemoradiotherapy. Int. J. Clin. Exp. Med. 2015;8:16215–16222. PubMed PMC

Tan B., Luo H.-Q., Xu H., Lv N.-H., Shi R.-H., Luo H.-S., Li J.-S., Ren J.-L., Zou Y.-Y., Li Y.-Q., et al. Polaprezinc combined with clarithromycin-based triple therapy for Helicobacter pylori-associated gastritis: A prospective, multicenter, randomized clinical trial. PLoS ONE. 2017;12:e0175625. doi: 10.1371/journal.pone.0175625. PubMed DOI PMC

Takaoka T., Sarukura N., Ueda C., Kitamura Y., Kalubi B., Toda N., Abe K., Yamamoto S., Takeda N. Effects of zinc supplementation on serum zinc concentration and ratio of apo/holo-activities of angiotensin converting enzyme in patients with taste impairment. Auris Nasus Larynx. 2010;37:190–194. doi: 10.1016/j.anl.2009.07.003. PubMed DOI

Masayuki F., Norihiko K., Keita T., Miwa I., Masayuki I., Toshihiko I., Hiromi F., Chikaaki M., Norio N. Efficacy and safety of polaprezinc as a preventive drug for radiation-induced stomatitis. Nihon Igaku Hoshasen Gakkai Zasshi. 2002;62:144–150. PubMed

Kitagawa J., Kobayashi R., Nagata Y., Kasahara S., Ono T., Sawada M., Ohata K., Kato-Hayashi H., Hayashi H., Shimizu M., et al. Polaprezinc for prevention of oral mucositis in patients receiving chemotherapy followed by hematopoietic stem cell transplantation: A multi-institutional randomized controlled trial. Int. J. Cancer. 2021;148:1462–1469. doi: 10.1002/ijc.33316. PubMed DOI

Jung D.H., Park J.C., Lee Y.C., Lee S.K., Shin S.K., Chung H., Park J.J., Kim J.-H., Youn Y.H., Park H. Comparison of the Efficacy of Polaprezinc Plus Proton Pump Inhibitor and Rebamipide Plus Proton Pump Inhibitor Treatments for Endoscopic Submucosal Dissection-induced Ulcers. J. Clin. Gastroenterol. 2021;55:233–238. doi: 10.1097/MCG.0000000000001357. PubMed DOI PMC

Hewlings S., Kalman D. A Review of Zinc-L-Carnosine and Its Positive Effects on Oral Mucositis, Taste Disorders, and Gastrointestinal Disorders. Nutrients. 2020;12:665. doi: 10.3390/nu12030665. PubMed DOI PMC

FDA (Food and Drug Administration) NDI 134—Zinc Carnosine—Original NDI Notification. Published Online 2007. [(accessed on 1 February 2023)]; Available online: https://www.regulations.gov/document/FDA-2003-S-0732-0044.

Reply to Child, R. Comment on "Cesak et al. Carnosine and Beta-Alanine Supplementation in Human Medicine: Narrative Review and Critical Assessment. Nutrients 2023, 15, 1770"